Comparison of low- and high-dose recombinant activated factor VII for postcardiac surgical bleeding.

about

Comparison of low- and high-dose recombinant activated factor VII for postcardiac surgical bleeding.

Item

http://www.wikidata.org/entity/Q42393855

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparison of low- and high-do ...... postcardiac surgical bleeding.

@en

Comparison of low- and high-do ...... postcardiac surgical bleeding.

@nl

type

Item

label

Comparison of low- and high-do ...... postcardiac surgical bleeding.

@en

Comparison of low- and high-do ...... postcardiac surgical bleeding.

@nl

prefLabel

Comparison of low- and high-do ...... postcardiac surgical bleeding.

@en

Comparison of low- and high-do ...... postcardiac surgical bleeding.

@nl

P1476

Comparison of low- and high-do ...... postcardiac surgical bleeding.

@en

P2093

Aly Makram Habib

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications

Recombinant factor VII is associated with worse survival in complex cardiac surgical patients

Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.

The Effect of Intravenous Administration of Active Recombinant Factor VII on Postoperative Bleeding in Cardiac Valve Reoperations; A Randomized Clinical Trial.

Limiting excessive postoperative blood transfusion after cardiac procedures. A review.

Recombinant Activated Factor VII Significantly Reduces Transfusion Requirements in Cardiothoracic Surgery.

Recombinant activated factor VII and the anaesthetist.

Recombinant activated factor VII in cardiac surgery: a systematic review.

Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations.

Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes.

P304

497-503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0972-5229.190365

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27688624

http://www.w3.org/2001/XMLSchema#string

P932

5027741

http://www.w3.org/2001/XMLSchema#string